This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Applied Materials, Inc.
CoreWeave
Outlook Therapeutics, Inc.
LiveRamp Holdings, Inc.
Regeneron Pharmaceuticals, Inc.
Applied Materials, Inc. AMAT | 0.00 | |
CoreWeave CRWV | 0.00 | |
Outlook Therapeutics, Inc. OTLK | 0.00 | |
LiveRamp Holdings, Inc. RAMP | 0.00 | |
Regeneron Pharmaceuticals, Inc. REGN | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc (NASDAQ:OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $0.23 on Friday. See how other analysts view this stock.
- Morgan Stanley analyst Shane Brett downgraded Applied Materials Inc (NASDAQ:AMAT) from Overweight to Equal-Weight and announced a $502 price target. Applied Materials shares closed at $436.62 on Friday. See how other analysts view this stock.
- DA Davidson analyst Gil Luria downgraded CoreWeave Inc (NASDAQ:CRWV) from Buy to Neutral and cut the price target from $175 to $100. CoreWeave shares closed at $107.30 on Friday. See how other analysts view this stock.
- Leerink Partners analyst Andrew Berens downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) from Outperform to Market Perform and slashed the price target from $792 to $641. Regeneron Pharmaceuticals shares closed at $698.25 on Friday. See how other analysts view this stock.
- DA Davidson analyst Clark Wright downgraded LiveRamp Holdings (NYSE:RAMP) from Buy to Neutral and raised the price target from $35 to $38.5. LiveRamp shares closed at $29.66 on Friday. See how other analysts view this stock.
Considering buying CRWV stock? Here’s what analysts think:
Photo via Shutterstock